ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Study Finds Increased Risk of CVD from TRT
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 154530" data-attributes="member: 13851"><p>This is one of the more recent papers regarding trt and cardiovascular risk!</p><p></p><p><a href="https://www.excelmale.com/forum/threads/testosterone-replacement-therapy-and-cardiovascular-risk.18830/" target="_blank">Testosterone replacement therapy and cardiovascular risk</a></p><p></p><p></p><p>Key points to keep in mind:</p><p></p><p><strong>•The TRAVERSE trial, the first trial of testosterone therapy that is adequately powered to assess cardiovascular events, began in 2018, <span style="color: rgb(184, 49, 47)">and its findings might take a decade to become available. </span></strong></p><p></p><p><strong>•<span style="color: rgb(184, 49, 47)">Until the results of the TRAVERSE trial are available,</span> clinicians should individualize testosterone treatment after having an informed discussion with their patients about the risks and benefits of testosterone replacement therapy. </strong></p><p></p><p></p><p></p><p></p><p></p><p><strong>Conclusions </strong></p><p><strong><span style="color: rgb(184, 49, 47)">Testosterone has an important role in cardiovascular physiology and metabolic health.</span> Although epidemiological data are conflicting, some retrospective studies support a beneficial effect of testosterone replacement therapy on mortality, whereas other reports suggest that testosterone might increase the risk of serious cardiovascular events, a finding that is also supported by some randomized trials. Meta-analyses also report conflicting results and are limited by the inclusion of low-to-medium quality trials</strong>.<strong> <span style="color: rgb(44, 130, 201)">Furthermore, to date, no published trials of testosterone replacement therapy have been adequately powered to assess cardiovascular events.</span></strong> <strong><span style="color: rgb(251, 160, 38)">Therefore, the TRAVERSE trial 41 will go a long way towards enabling an assessment of the cardiovascular safety of testosterone therapy.</span></strong> <strong><span style="color: rgb(26, 188, 156)">In the interim, clinicians should guide their patients in making informed decisions by having an open discussion about the current evidence on the cardiovascular safety of testosterone replacement therapy</span></strong></p></blockquote><p></p>
[QUOTE="madman, post: 154530, member: 13851"] This is one of the more recent papers regarding trt and cardiovascular risk! [URL='https://www.excelmale.com/forum/threads/testosterone-replacement-therapy-and-cardiovascular-risk.18830/']Testosterone replacement therapy and cardiovascular risk[/URL] Key points to keep in mind: [B]•The TRAVERSE trial, the first trial of testosterone therapy that is adequately powered to assess cardiovascular events, began in 2018, [COLOR=rgb(184, 49, 47)]and its findings might take a decade to become available. [/COLOR][/B] [B]•[COLOR=rgb(184, 49, 47)]Until the results of the TRAVERSE trial are available,[/COLOR] clinicians should individualize testosterone treatment after having an informed discussion with their patients about the risks and benefits of testosterone replacement therapy. [/B] [B]Conclusions [COLOR=rgb(184, 49, 47)]Testosterone has an important role in cardiovascular physiology and metabolic health.[/COLOR] Although epidemiological data are conflicting, some retrospective studies support a beneficial effect of testosterone replacement therapy on mortality, whereas other reports suggest that testosterone might increase the risk of serious cardiovascular events, a finding that is also supported by some randomized trials. Meta-analyses also report conflicting results and are limited by the inclusion of low-to-medium quality trials[/B].[B] [COLOR=rgb(44, 130, 201)]Furthermore, to date, no published trials of testosterone replacement therapy have been adequately powered to assess cardiovascular events.[/COLOR][/B] [B][COLOR=rgb(251, 160, 38)]Therefore, the TRAVERSE trial 41 will go a long way towards enabling an assessment of the cardiovascular safety of testosterone therapy.[/COLOR][/B] [B][COLOR=rgb(26, 188, 156)]In the interim, clinicians should guide their patients in making informed decisions by having an open discussion about the current evidence on the cardiovascular safety of testosterone replacement therapy[/COLOR][/B][COLOR=rgb(26, 188, 156)] [/COLOR] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Study Finds Increased Risk of CVD from TRT
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top